Filing metadata

Accession number
0001567619-22-022014
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Dec 27, 2022
Reporting period
Dec 22, 2022
Description
Insider transaction

Explore SEC Filings Hub